Hideaki Takahashi

Hideaki Takahashi

Auto-generated profile, based on publicly available information

Hideaki Takahashi

Niigata Bone Science Institute, Niigata, Japan; and

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 December 2012 in Cancer Chemotherapy and Pharmacology
Verified
Journal Article
Closed access
PDF file
SSSoichiro Shibui
Soichiro Shibui
YNYOSHITAKA NARITA
YOSHITAKA NARITA
JMJunki Mizusawa
Junki Mizusawa
TBTakaaki Beppu
Takaaki Beppu
KOKuniaki Ogasawara
Kuniaki Ogasawara
KNKazuhiro Nomura
Kazuhiro Nomura

18 November 2011 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
YTYuuki Tsuchihashi
Yuuki Tsuchihashi
TSTomimasa Sunagawa
Tomimasa Sunagawa
YYYuichiro Yahata
Yuichiro Yahata
HTHideaki Takahashi
Hideaki Takahashi
TTTakao Toyokawa
Takao Toyokawa
NONobuhiko Okabe
Nobuhiko Okabe
We assessed the effect of seasonal trivalent inactivated influenza vaccination (TIV) on pandemic influenza 2009 (pH1N1)–related illness from April to June 2009 among 2849 students (aged 12–18 years). TIV was associated with an increase in the frequency of pH1N1-related illness among subjects (adjusted odds ratio, 1.47; 95% confidence interval, 1.14–1.89). TIV during the 2008-2009 season increased the risk of pH1N1-related illness from April to June 2009.

1 March 2022 in Journal of Neurosurgery: Spine
Verified
Journal Article
Closed access
PDF file
KSKimihiko Sawakami
Kimihiko Sawakami
KWKei Watanabe
Kei Watanabe
KHKazuhiro Hasegawa
Kazuhiro Hasegawa
NYNoriaki Yamamoto
Noriaki Yamamoto
TSTaketoshi Shimakura
Taketoshi Shimakura
HTHideaki E. Takahashi
Hideaki E. Takahashi
OBJECTIVE: Teriparatide (TPTD) is a potent promoter of early-stage osteogenesis and may be a useful adjuvant therapy to reduce complications related to bone fragility in spinal surgery patients with osteoporosis. However, effective neoadjuvant TPTD therapy regimens remain poorly understood. This study aimed to examine the effect of preoperative TPTD administration on cancellous bone with bone histomorphometry and to clarify the timing of preoperative TPTD administration for patients with spinal fusion and osteoporosis. METHODS: In this longitudinal multicenter study, 57 patients with spinal fusion and osteoporosis, who consented to undergo iliac biopsy, were allocated to the following treatment groups: neoadjuvant TPTD therapy group (n = 42) and no neoadjuvant therapy (NTC) group (n = 15). Patients in the TPTD group were categorized into subgroups on the basis of duration of preoperative TPTD administration, as follows: 1 month (n = 9), 2 months (n = 8), 3 months (n = 9), 4 months (n = 7), and 6 months (n = 9). All patient samples were preoperatively double labeled with tetracycline, and iliac biopsies were performed during spinal fusion surgery. Histomorphometric analyses were performed on nondecalcified, thin-sliced specimens. Specimens were classified on the basis of TPTD administration duration and subsequently compared with those of the NTC group. Postoperative complications and Oswestry Disability Index scores were evaluated at 1 and 2 years after surgery. RESULTS: There were no demographic differences between groups. Mineralizing surface/bone surface, a key parameter of dynamic bone formation, started to increase after 1 month of TPTD administration; this increase became significant after 3 months of administration and peaked at 4 months, with a 6-fold increase relative to that of the NTC group. The patients who received preoperative TPTD for 3 months or more had superior clinical results in terms of the osteoporotic complication rate and Oswestry Disability Index scores, except for bisphosphonate-pretreated patients. CONCLUSIONS: When considering neoadjuvant TPTD therapy, the authors recommend at least 3 months of preoperative administration to provide a more substantial anabolic effect from the early postoperative stage.

13 September 2017 in The Anatomical Record
Verified
Journal Article
Closed access
PDF file
HTHideaki Takahashi
Hideaki Takahashi
HTHiroyuki Tamaki
Hiroyuki Tamaki
MOMineo Oyama
Mineo Oyama
NYNoriaki Yamamoto
Noriaki Yamamoto
HOHideaki Onishi
Hideaki Onishi

20 October 2009 in Journal of Interprofessional Care
Verified
Journal Article
Closed access
PDF file
HTHideaki E Takahashi
Hideaki E Takahashi
(2009). Establishment of the Japan Association for Interprofessional Education and perspectives. Journal of Interprofessional Care: Vol. 23, No. 6, pp. 554-555. doi: 10.3109/13561820903328750

3 January 2018 in The Anatomical Record
Verified
Journal Article
Open access
PDF file
KHKeishi Hayao
Keishi Hayao
HTHiroyuki Tamaki
Hiroyuki Tamaki
KNKouki Nakagawa
Kouki Nakagawa
KTKeigo Tamakoshi
Keigo Tamakoshi
HTHideaki Takahashi
Hideaki Takahashi
HOHideaki Onishi
Hideaki Onishi
The purpose of this study was to investigate the preventive effect of streptomycin (Str) administration on changes in membrane permeability and the histomorphological characteristics of damaged muscle fibers following eccentric contraction (ECC ). Eighteen 7‐week‐old male Fischer 344 rats were randomly assigned to three groups: control (Cont), ECC, and ECC with Str (ECC + Str). The tibialis anterior (TA) muscles in both ECC groups were stimulated electrically and exhibited ECC. Evans blue dye (EBD), a marker of muscle fiber damage associated with increased membrane permeability, was injected 24 hr before TA muscle sampling. The number of EBD‐positive fibers, muscle fiber cross‐sectional area (CSA), and roundness were determined via histomorphological analysis. The ECC intervention resulted in an increased fraction of EBD‐positive fibers, a larger CSA, and decreased roundness. The fraction of EBD‐positive fibers was 79% lower in the ECC + Str group than in the ECC group. However, there was no difference in the CSA and roundness of the EBD‐positive fibers between the two ECC groups. These results suggest that Str administration can reduce the number of myofibers that increase membrane permeability following ECC, but does not ameliorate the extent of fiber swelling in extant EBD‐positive fibers. Anat Rec, 301:1096–1102, 2018.